Omar Zazay Wins First WSOP Bracelet for $538,158
Zazay outlasts 1,300 entries and Jean-Robert Bellande in $3,000 NLHE Event #32

Omar Zazay claimed his first World Series of Poker bracelet this week, outlasting 1,300 entries in Event #32: $3,000 No-Limit Hold'em to defeat Jean-Robert Bellande heads-up and collect $538,158, according to PokerNews.
Why It Matters
A $538,158 top prize from a $3,000 buy-in represents a return of roughly 179x — the kind of upside that keeps mid-stakes tournament fields competitive and deep. Zazay's victory over a seasoned television personality in Bellande adds a narrative layer that raises the event's profile beyond a routine bracelet. For recreational players weighing live tournament investment, results like this reinforce the appeal of WSOP $3,000-range events, which offer bracelet prestige at a fraction of the Main Event's $10,000 entry cost. As of June 2026, the WSOP remains the primary driver of high-volume live poker participation globally. Gambling involves real financial risk; tournament poker outcomes are inherently variable regardless of skill level.
Context
Jean-Robert Bellande is a recurring figure in high-profile poker media, known for deep runs and an outsized social presence, making him a credible final-table obstacle. The $3,000 NLHE format sits in a sweet spot — expensive enough to thin recreational variance, accessible enough to draw 1,300 entries and build a substantial prize pool.
What's Next
Zazay enters the remainder of the 2026 WSOP schedule as a bracelet winner, a status that typically elevates a player's table draw difficulty and sponsorship visibility. The WSOP Main Event, the series' marquee $10,000 buy-in finale, represents the logical next target for any bracelet holder building momentum.
Keep reading
WeeBet Weekly
The week's biggest market move, in 4 minutes.
Every Friday: the top Polymarket and Kalshi price shift, one regulatory story that actually matters, and one chart. No fluff, no promo. Free.
Free. Unsubscribe in one click. We'll never sell your email.